Grants per year
Personal profile
Research Interests
Dr. Choi is the Chief of the Division of Oncodermatology at Robert H. Lurie Comprehensive Cancer Center. She specializes in providing skin care for patients undergoing cancer treatment. Her expertise includes knowledge in recognizing and managing side effects from chemotherapy, including rashes, very dry skin, itching, nail and hair changes, cutaneous metastases, radiation dermatitis and other changes due to radiation, infections in immunosuppressed patients, and toxicities that may arise as a result of stem cell or solid organ transplantation, including graft-versus-host disease and advanced skin cancer. She directs the Inpatient Dermatology Consult service for the Cancer Center, as well as the comprehensive skin care and skin cancer surveillance program for high-risk patients and all cancer survivors. She also helps to oversee Northwestern Memorial’s extracorporeal photopheresis unit. Additionally, she is director of clinical research trials investigating the prevention and treatment of cancer therapy-related side effects. She believes strongly in treating patients with attentive care and true compassion. Dr. Choi also specializes in treating patients with skin cancer, including melanoma, squamous cell carcinoma and basal cell carcinoma. She is Co-Leader of the Skin Disease Team and an integral member of the Northwestern Melanoma Unit. For all skin cancer patients, she conducts rigorous screening skin examinations on a regular basis to detect skin cancers and sun damage to optimize prevention and therapy. She is experienced with surgical treatment of skin cancers, as well as non-surgical methods to treat skin cancer and precancerous lesions. Dr. Choi also runs a full medical and surgical dermatology practice. She is experienced with the use of complex dermatologic therapy, including biologic therapy, immunosuppressive medications, and phototherapy. Dr. Choi received her BA degree from Harvard University and her MD degree from Yale University School of Medicine. She completed internship in Internal Medicine at Brigham and Women's Hospital/Harvard Medical School and residency in Dermatology at Yale, where she served as Chief Resident.
Certifications and Licenses
American Board of Dermatology |
Training Experience
2002 | Postdoctoral Fellowship, Yale University |
2004 | Internship, Brigham & Women's Hospital |
2007 | Residency, Yale University |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MD, Medicine, Yale University
… → 2003
Research interests keywords
- Cancer Survivorship
- Chemotherapy
- Melanoma
- Skin Cancer
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Instances and Clinical Characteristics of Subsequent Primary Cutaneous Malignancy Following First Primary Cancer Diagnosis
Choi, J. N. (PD/PI)
2/1/22 → 2/1/23
Project: Research project
-
Prot #INCB 18424-365/CINC424D2301: A Phase III, Randomized, Open-Label, Multi-Center Study of Ruxolitinib Versus Best Available Therapy in Patients with Corticosteroid-Refractory Chronic Graft Versus Host Disease After Allogenic Stem Cell Transplantation
Choi, J. N. (PD/PI)
DrugDev Inc., Incyte Corporation
1/9/18 → 8/31/22
Project: Research project
-
Prot #2017-VBP-926: A Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Phase-2 Trial to Evaluate the Efficacy and Safety of Two Concentrations of Topical Povidone-Iodine Nail Solution (VBP-926) for the Treatment of Chemotherapy-Associated Paron
Choi, J. N. (PD/PI)
JSS Medical Research India Pvt. Ltd., Veloce BioPharma LLC
11/16/17 → 11/16/20
Project: Research project
-
Acute Graft-Versus-Host Disease: Diagnostic Challenges and Multidisciplinary Management in the Inpatient Setting
Lenga, M., Choi, E., Lin, J. & Choi, J. N., Dec 2025, In: Current Dermatology Reports. 14, 1, 3.Research output: Contribution to journal › Review article › peer-review
-
Eruptive nevi in the setting of encorafenib: A case report and literature review
Lenga, M., Venkatesh, S. & Choi, J. N., Feb 2025, In: JAAD Case Reports. 56, p. 23-26 4 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Recommended guidelines for screening for underlying malignancy in extramammary Paget's disease based on anatomic subtype
Extramammary Paget's Disease Guideline Study Group, Feb 2025, In: Journal of the American Academy of Dermatology. 92, 2, p. 261-268 8 p.Research output: Contribution to journal › Article › peer-review
-
USCOM V: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
Choi, J. N., Lacouture, M., Andriessen, A., Ho, A., McLellan, B., Mitchell, E. & Leventhal, J., Apr 2025, In: Journal of Drugs in Dermatology. 24, 4, p. s3-s14Research output: Contribution to journal › Article › peer-review
-
Anatomic Subtype Differences in Extramammary Paget Disease: A Meta-Analysis
Kibbi, N., Owen, J. L., Worley, B., Wang, J. X., Harikumar, V., Aasi, S. Z., Chandra, S., Choi, J. N., Fujisawa, Y., Iavazzo, C., Kim, J. Y. S., Lawrence, N., Leitao, M. M., MacLean, A. B., Ross, J. S., Rossi, A. M., Servaes, S., Solomon, M. J. & Alam, M., Apr 17 2024, In: JAMA dermatology. 160, 4, p. 417-424 8 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations
Datasets
-
Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management
Musiek, A. C. M. (Creator), Rieger, K. E. (Creator), Bagot, M. (Creator), Choi, J. N. (Creator), Fisher, D. C. (Creator), Guitart, J. (Creator), Haun, P. L. (Creator), Horwitz, S. M. (Creator), Huen, A.O.-L. (Creator), Kwong, B. Y. (Creator), Lacouture, M. E. (Creator), Noor, S. J. (Creator), Rook, A. H. (Creator), Seminario-Vidal, L. (Creator), Vermeer, M. H. (Creator) & Kim, Y. H. (Creator), Adis Journals, 2021
DOI: 10.6084/m9.figshare.16677523.v1, https://adisjournals.figshare.com/articles/media/Dermatologic_Events_Associated_with_the_Anti-CCR4_Antibody_Mogamulizumab_Characterization_and_Management/16677523/1
Dataset
-
Skin rash composition after checkpoint inhibitor therapy varies by therapeutic regimen
Bhuva, D. (Contributor), Choi, J. (Contributor), Cosgrove, C. (Contributor), Hong, S. (Contributor), Jaishankar, D. (Contributor), Kosche, C. (Contributor), Le Poole, I. C. (Contributor), Li, L. (Contributor), Munir, S. (Contributor), Perez White, B. (Contributor), Ramesh, P. (Creator), Shivde, R. (Contributor) & Zhang, H. (Contributor), Mendeley Data, 2022
DOI: 10.17632/hw4j2k8xt3.1, https://data.mendeley.com/datasets/hw4j2k8xt3
Dataset